R. Ozaras Et Al. , "Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe," HEPATOLOGY , vol.64, no.5, pp.1825-1827, 2016
Ozaras, R. Et Al. 2016. Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe. HEPATOLOGY , vol.64, no.5 , 1825-1827.
Ozaras, R., SÜNBÜL, M., PARLAK, M., Bodur, H., & Leblebicioglu, H., (2016). Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe. HEPATOLOGY , vol.64, no.5, 1825-1827.
Ozaras, Resat Et Al. "Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe," HEPATOLOGY , vol.64, no.5, 1825-1827, 2016
Ozaras, Resat Et Al. "Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe." HEPATOLOGY , vol.64, no.5, pp.1825-1827, 2016
Ozaras, R. Et Al. (2016) . "Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe." HEPATOLOGY , vol.64, no.5, pp.1825-1827.
@article{article, author={Resat Ozaras Et Al. }, title={Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe}, journal={HEPATOLOGY}, year=2016, pages={1825-1827} }